ORIGINAL
Evaluación económica de la desvenlafaxina en el tratamiento de la depresión mayor en España
Economic evaluation of desvenlafaxine in the treatment of major depressive disorder in Spain
Javier Rejas Gutiérreza,
, Milagrosa Blanca Tamayob, Josep Gascón Barrachinac, Beatriz Armada Peláezd
Autor para correspondencia
a Departamento de Farmacoeconomía e Investigación de Resultados en Salud, Pfizer, S. L. U., Alcobendas, Madrid, España
b Unidad de Psiquiatría, Servicio de Medicina, Badalona Serveis Assistencials S. A., Badalona, Barcelona, España
c Servicio de Psiquiatría, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona, España
d Departamento Médico, Pfizer, S. L. U., Alcobendas, Madrid, España
Leído
12353
Vecesse ha leído el artículo
2077
Total PDF
10276
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 64 | 35 | 99 |
| 2025 11 | 207 | 57 | 264 |
| 2025 10 | 207 | 10 | 217 |
| 2025 9 | 182 | 23 | 205 |
| 2025 8 | 199 | 31 | 230 |
| 2025 7 | 139 | 6 | 145 |
| 2025 6 | 132 | 6 | 138 |
| 2025 5 | 177 | 13 | 190 |
| 2025 4 | 192 | 16 | 208 |
| 2025 3 | 176 | 18 | 194 |
| 2025 2 | 138 | 12 | 150 |
| 2025 1 | 110 | 23 | 133 |
| 2024 12 | 115 | 8 | 123 |
| 2024 11 | 81 | 12 | 93 |
| 2024 10 | 110 | 25 | 135 |
| 2024 9 | 118 | 23 | 141 |
| 2024 8 | 141 | 19 | 160 |
| 2024 7 | 153 | 5 | 158 |
| 2024 6 | 126 | 10 | 136 |
| 2024 5 | 83 | 10 | 93 |
| 2024 4 | 102 | 26 | 128 |
| 2024 3 | 102 | 9 | 111 |
| 2024 2 | 120 | 14 | 134 |
| 2024 1 | 97 | 6 | 103 |
| 2023 12 | 104 | 9 | 113 |
| 2023 11 | 131 | 12 | 143 |
| 2023 10 | 185 | 13 | 198 |
| 2023 9 | 144 | 9 | 153 |
| 2023 8 | 119 | 7 | 126 |
| 2023 7 | 163 | 10 | 173 |
| 2023 6 | 228 | 13 | 241 |
| 2023 5 | 347 | 7 | 354 |
| 2023 4 | 181 | 7 | 188 |
| 2023 3 | 152 | 15 | 167 |
| 2023 2 | 109 | 22 | 131 |
| 2022 1 | 112 | 40 | 152 |
| 2022 12 | 97 | 41 | 138 |
| 2022 11 | 136 | 19 | 155 |
| 2022 10 | 99 | 31 | 130 |
| 2022 9 | 77 | 47 | 124 |
| 2022 8 | 64 | 40 | 104 |
| 2022 7 | 65 | 31 | 96 |
| 2022 6 | 59 | 15 | 74 |
| 2022 5 | 53 | 19 | 72 |
| 2022 4 | 61 | 23 | 84 |
| 2022 3 | 62 | 10 | 72 |
| 2022 2 | 60 | 13 | 73 |
| 2021 1 | 95 | 18 | 113 |
| 2021 12 | 56 | 38 | 94 |
| 2021 11 | 159 | 52 | 211 |
| 2021 10 | 142 | 45 | 187 |
| 2021 9 | 99 | 14 | 113 |
| 2021 8 | 114 | 12 | 126 |
| 2021 7 | 74 | 18 | 92 |
| 2021 6 | 47 | 19 | 66 |
| 2021 5 | 101 | 35 | 136 |
| 2021 4 | 172 | 36 | 208 |
| 2021 3 | 61 | 23 | 84 |
| 2021 2 | 38 | 13 | 51 |
| 2020 1 | 64 | 22 | 86 |
| 2020 12 | 55 | 17 | 72 |
| 2020 11 | 128 | 50 | 178 |
| 2020 10 | 116 | 19 | 135 |
| 2020 9 | 67 | 16 | 83 |
| 2020 8 | 69 | 17 | 86 |
| 2020 7 | 49 | 20 | 69 |
| 2020 6 | 46 | 22 | 68 |
| 2020 5 | 37 | 10 | 47 |
| 2020 4 | 43 | 7 | 50 |
| 2020 3 | 55 | 11 | 66 |
| 2020 2 | 42 | 11 | 53 |
| 2020 1 | 40 | 13 | 53 |
| 2019 12 | 87 | 25 | 112 |
| 2019 11 | 43 | 10 | 53 |
| 2019 10 | 67 | 11 | 78 |
| 2019 9 | 63 | 17 | 80 |
| 2019 8 | 59 | 8 | 67 |
| 2019 7 | 71 | 18 | 89 |
| 2019 6 | 106 | 26 | 132 |
| 2019 5 | 222 | 58 | 280 |
| 2019 4 | 70 | 26 | 96 |
| 2019 3 | 37 | 16 | 53 |
| 2019 2 | 22 | 9 | 31 |
| 2019 1 | 32 | 7 | 39 |
| 2018 12 | 15 | 14 | 29 |
| 2018 11 | 30 | 14 | 44 |
| 2018 10 | 54 | 26 | 80 |
| 2018 9 | 59 | 5 | 64 |
| 2018 8 | 19 | 4 | 23 |
| 2018 7 | 20 | 9 | 29 |
| 2018 6 | 17 | 5 | 22 |
| 2018 5 | 13 | 14 | 27 |
| 2018 4 | 24 | 2 | 26 |
| 2018 3 | 21 | 2 | 23 |
| 2018 2 | 13 | 8 | 21 |
| 2018 1 | 23 | 0 | 23 |
| 2017 12 | 20 | 5 | 25 |
| 2017 11 | 32 | 3 | 35 |
| 2017 10 | 36 | 8 | 44 |
| 2017 9 | 22 | 8 | 30 |
| 2017 8 | 47 | 4 | 51 |
| 2017 7 | 30 | 7 | 37 |
| 2017 6 | 32 | 23 | 55 |
| 2017 5 | 39 | 18 | 57 |
| 2017 4 | 26 | 13 | 39 |
| 2017 3 | 49 | 8 | 57 |
| 2017 2 | 85 | 4 | 89 |
| 2016 1 | 45 | 6 | 51 |
| 2016 12 | 43 | 7 | 50 |
| 2016 11 | 55 | 3 | 58 |
| 2016 10 | 86 | 24 | 110 |
| 2016 9 | 89 | 15 | 104 |
| 2016 8 | 46 | 15 | 61 |
| 2016 7 | 64 | 8 | 72 |
| 2016 6 | 84 | 56 | 140 |
| 2016 5 | 82 | 48 | 130 |
| 2016 4 | 29 | 32 | 61 |
Mostrar todo